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Abstract
The incidence of thyroid metastasis among colorectal cancer patients is extremely rare. We report a case of colonic
adenocarcinoma metastasis to the thyroid gland with treatment of lung and liver metastases, in a 61-year-old
woman with a history of colon cancer. She showed a thyroid mass related to a 3-month history of hoarseness.
Physical and imaging examinations disclosed a diffuse large thyroid mass with swollen cervical lymph nodes.
Fine-needle aspiration cytology of the thyroid mass suggested malignancy. The patient underwent total
thyroidectomy. Histopathological examination and immunohistochemical staining revealed adenocarcinoma,
which was consistent with a diagnosis of metastases from primary colon cancer to the thyroid and cervical lymph
nodes. At 2 years after thyroid surgery, the patient has been continuing outpatient chemotherapy for the lung
and liver metastases. Thyroidectomy appeared to both relieve the patient and prevent local symptoms.
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Background
Clinically evident metastatic disease to the thyroid gland
is rare. Metastases from non-thyroid malignancies to the
thyroid gland have been reported in 1.4 to 3 % of all
patients who have surgery for suspected cancer in the
thyroid gland [1]. The incidence among colorectal
cancer patients is rare. We, herein, report the case of a
patient with a history of colon cancer which metasta-
sized to the thyroid. Approval from our hospital's Insti-
tutional Review Board was obtained for this case report.
Case presentation
A 61-year-old woman with a 3-month history of
hoarseness was referred to our department for evaluation
of a thyroid mass. Her family history was noncontributory.
Five years previously, she had undergone an excision of
the sigmoid colon for well-differentiated adenocarcinoma
of the sigmoid colon (pSS, pN0, M0 stage II). At 1 year
and 8 months after the surgery, a computed tomography
(CT) scan performed as part of a postoperative follow-up
study revealed a metastasis in S10 of the left lung.
The patient underwent a left lung basal segmentect-
omy. Postoperatively, she received chemotherapy with
modified FOLFOX6. At 1 year and 3 months after
the second surgery, a CT scan detected asynchronous
multiple lung metastases in S6 of the right lung, S3
and S5 of the left lung, and the left lower lobe. At
6 months after the lung metastasis detection, she
underwent a thoracoscopic lung surgery of partial
resection of S6 of the right lung and S3 and S5 of
the left lung and a left lung lower lobectomy. After
these procedures, she received oral chemotherapy
with S-1. At 10 months after the third surgery, she
underwent a laparoscopic partial hepatectomy for
liver metastasis in S5 of the liver.
At 7 months after liver surgery, she noticed a swelling
in the front of her neck and gradually felt increasing
hoarseness. Physical examination revealed a hard diffuse
goiter, 8 × 6 cm in size. Also, hard enlarged lymph nodes
were palpated in the cervical lymph node region. The
laboratory data revealed no anemia and no abnormalities
in the liver, renal, or thyroid function, but serum levels
of carcinoembryonic antigen and thyroglobulin were
found to be elevated at 9.8 ng/ml (normal 0.0 to
5.5 ng/ml) and 176.8 ng/ml (0.0 to 32.7 ng/ml),
respectively.
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Ultrasonography disclosed a hypoechoic mass in the
thyroid and swollen bilateral cervical lymph nodes
(Fig. 1). CT scans revealed a low-density widespread
mass in the thyroid and swollen bilateral cervical lymph
nodes. There was no evidence of invasion of the trachea.
At this time, chest CTs showed several small lung
metastases and a single metastasis of the liver at S8. The
patient underwent fine-needle aspiration cytology
(FNAC) of the thyroid tumor. FNAC showed tumor cell
clusters that were suspected to be thyroid papillary
carcinoma, suggesting malignancy.
Subsequently, the patient underwent a total thyroidec-
tomy and bilateral cervical lymph nodes dissection.
Intraoperatively, the tumor was found to involve the
right recurrent laryngeal nerve, which had to be sacri-
ficed. Histopathological examination showed cribriform
nests of tall columnar cells accompanied by necrosis.
These results suggested adenocarcinoma, not papillary
carcinoma. The lesion occupied almost the entirety of
the thyroid (Fig. 1). Next, immunohistochemical (IHC)
staining was performed using cytokeratin 7 (CK7), cyto-
keratin 20 (CK20), and thyroid transcription factor-1
(TTF-1), in order to clarify the origin of the tumor. The
tumor cell test results were positive for CK20 and
negative for CK7 and TTF-1 (Fig. 2). Histopathological
and IHC examinations of the cervical lymph nodes
metastases showed the same results as in the thyroid
tumor (Fig. 3). These findings were consistent with
colon cancer metastasis, although we did note that the
cervical lymph nodes metastases were similar to those in
thyroid cancer cases. Therefore, it appeared clear that
the thyroid tumor was a metastasis from the colon
carcinoma. The patient was discharged from our
hospital on the seventh postoperative day. At 2 years
after thyroid surgery, the patient has been continuing
outpatient chemotherapy for the lung and liver
metastases.
Discussion
Metastases to the thyroid gland are uncommon. The
incidence of thyroid metastasis among colorectal cancer
patients is quite low: this diagnosis is applied to 6
patients (0.1 %) out of a total of 5862 colorectal cancer
patients [1]. Recently, Chung et al. [2] reviewed all
clinical reports available in the literature from 2000 to
2010 including case reports and case series. In this
analysis of thyroid metastases, primary cancers were
identified as renal (48.0 % of cases), colorectal (10.4 %),
lung (8.3 %), breast (7.8 %), or sarcoma (4.0 %).
While 60 to 80 % of metastases are metachronous
(following previously treated malignancy), 20 to 40 % are
synchronous (simultaneous) with the primary lesion [3].
In metachronous metastases, the mean and median
intervals between diagnosing primary malignancies and
their metastases to the thyroid gland were reported at
69.9 and 53 months, respectively [2]. The mean interval
between discovery of primary tumor and of thyroid
metastasis was 68 months for renal cancer, 48.2 months
for breast cancer, 41.5 months for colorectal cancer, and
20.9 months for malignant melanoma. Another report
indicated a very poor prognosis for thyroid metastasis
from colorectal cancer: a cancer-related death rate of
50 % in less than a year [3]. For such cases, systemic
management depending on the primary colon cancer
may contribute to longer survival following thyroid
surgery.
Froylich et al. [4] reviewed metachronous colon metas-
tasis to the thyroid. The authors found 34 cases; two
Fig. 1 Ultrasound and CT scan findings. a Ultrasonography shows a
hypoechoic mass in the thyroid. b Swollen bilateral cervical lymph
nodes. c Low-density mass is spread in the thyroid with no evidence
of invasion of the trachea
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Fig. 2 Histopathological and immunohistochemical (IHC) staining findings of the thyroid. a Gross findings reveal an ill-defined white diffuse mass. bMicroscopic
findings show cribriform nests of tall columnar cells accompanied by necrosis (H&E stain, ×400). c IHC staining for TTF-1 reveals negative staining in the tumor
cells. d IHC staining for cytokeratin 7 shows negative staining in the tumor cells. e IHC staining for cytokeratin 20 shows cytoplasmic positivity in the tumor cells
Fig. 3 Histopathological and immunohistochemical (IHC) staining findings of the cervical lymph nodes. a Microscopic findings show cribriform nests
of tall columnar cells in one of the affected lymph nodes (H&E stain, ×400). b IHC staining for TTF-1 reveals negative staining in the tumor cells. c IHC
staining for cytokeratin 7 shows negative staining in the tumor cells. d IHC staining for cytokeratin 20 shows cytoplasmic positivity in the tumor cells
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thirds of the patients were female and patient age ranged
from 34 to 85. The metastases’ primary sites were the
rectum (41 %), sigmoid colon (33 %), right colon (19 %),
or left colon (11 %). The staging of the colon carcinoma
was stage III or IV in 75 % of the patients. Metastasis to
the thyroid was diagnosed 6 months to 8 years after
colonic resection. In our case, the staging of the sigmoid
colon cancer was stage II. The thyroid metastasis was
revealed at 5 years after sigmoid colon cancer surgery.
Although a high sensitivity has been reported for FNA
in patients with various metastatic carcinomas to the
thyroid gland, the accuracy of FNA is around 50 %
[5, 6]. IHC is usually able to differentiate between pri-
mary thyroid malignancy and secondary malignancy [7, 8].
In general, thyroid tumor test results are positive for CK7
and negative for CK20. In contrast, colon cancer results
are almost always positive for CK20 and negative for CK7.
In our case, the tumor cell results were positive for CK20
and negative for CK7.
The role of surgery for treating thyroid metastasis is
unclear. Thyroidectomy constitutes better palliation of
respiratory symptoms than mere observation [9]. Local
control of metastatic disease in the central compartment
of the neck can be successfully achieved with minimal
morbidity with surgical resection in selected patients [5].
Nonsurgical treatments, such as radiotherapy and
chemotherapy, have been used for patients deemed
inoperable, although the impact of these modalities
remains uncertain [10]. Although our patient had
recurrent laryngeal nerve palsy, surgery appeared to give
her relief and prevention from local symptoms.
Conclusions
In conclusion, thyroidectomy in a thyroid metastasis
patient appeared to both relieve the patient and prevent
the occurrence of local symptoms.
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